How did AstraZeneca's gross margin improve in Q2 2024 compared to Q2 2023?
3/31/2025 11:31am
AstraZeneca's gross margin improved by 1.3% in Q2 2024 compared to Q2 2023, reaching 82.66%. This indicates a strengthening in the company's profitability and operational efficiency during the period.
|code|Ticker|Name|Date|Gross Profit Margin|Gross Profit Margin YoY|market_code|
|---|---|---|---|---|---|---|
|AZN|AZN.O|Astrazeneca|2023 Q3|82.3601|15.407984104096869|185|
|AZN|AZN.O|Astrazeneca|2023 Q4|81.9519|13.724943277617035|185|
|AZN|AZN.O|Astrazeneca|2024 Q1|82.5065|0.020972442453079755|185|
|AZN|AZN.O|Astrazeneca|2024 Q2|82.82|0.18835216653379508|185|